Table 2 Angiographic Characteristics and Procedural Details
No Diabetes | Diabetes | p Value | |
|---|---|---|---|
(n = 702) | (n = 374) | ||
Vascular lesion, n% | |||
LM lesion | 129(18.38) | 82(21.93) | 0.163 |
LAD lesion | 578(82.34) | 323(86.36) | 0.088 |
LCX lesion | 483(68.80) | 303(81.02) | < 0.001 |
RCA lesion | 552(78.63) | 301(80.48) | 0.476 |
Multivessel disease, n% | 587(83.62) | 344(91.98) | < 0.001 |
Number of lesions per patient | 2.40 ± 0.98 | 2.61 ± 0.93 | 0.001 |
Location of the CTO, n% | |||
LM-CTO | 7(1.00) | 3(0.80) | 0.751 |
LAD-CTO | 327(46.58) | 169(45.19) | 0.662 |
LCX-CTO | 202(28.77) | 120(32.09) | 0.259 |
RCA-CTO | 403(57.41) | 232(62.03) | 0.142 |
Multi-CTO lesion, n% | 205(29.20) | 126(33.69) | 0.129 |
Number of CTO per patient | 1.34 ± 0.56 | 1.40 ± 0.61 | 0.087 |
CTO target vessel, n% | |||
LM-CTO | 5(0.71) | 3(0.80) | 0.870 |
LAD-CTO | 272(38.75) | 141(37.70) | 0.737 |
LCX-CTO | 107(15.24) | 52(13.90) | 0.556 |
RCA-CTO | 347(49.43) | 192(51.34) | 0.551 |
Ostial location, n% | 68(9.69) | 39(10.43) | 0.699 |
In-stent occlusion, n% | 50(7.12) | 39(10.43) | 0.061 |
Lesion length, mm | 27.85 ± 20.57 | 28.39 ± 16.96 | 0.672 |
Lesion length ≥ 20 mm, n% | 450(64.10) | 255(68.18) | 0.180 |
Blunt stump, n% | 463(66.00) | 270(72.19) | 0.037 |
Tortuosity ≥ 45°, n% | 194(27.64) | 112(29.95) | 0.424 |
Calcification, n% | 212(30.20) | 144(38.50) | 0.006 |
Reattempt, n% | 104(14.81) | 66(17.65) | 0.225 |
J-CTO score | 2.11 ± 1.13 | 2.31 ± 1.15 | 0.005 |
Proximal cap side-branch, n% | 526(74.93) | 287(76.74) | 0.511 |
“Interventional” collaterals, n% | 496(70.66) | 266(71.12) | 0.809 |
Diseased distal landing zone, n% | 335(47.72) | 200(53.48) | 0.072 |
Contrast volume, ml | 363.64 ± 203.53 | 362.99 ± 245.91 | 0.963 |
Procedural time, min | 119.14 ± 69.29 | 117.21 ± 69.97 | 0.667 |
Procedural success, n% | 640(91.17) | 342(91.44) | 0.879 |